2-(4,5-Dihydro-1H-imidazol-2-yl)indazole (indazim) derivatives as selective I2 imidazoline receptor ligands
- 2 October 2003
- journal article
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 20 (2), 201-208
- https://doi.org/10.1016/s0928-0987(03)00182-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Induction of reactive astrocytosis and prevention of motoneuron cell death by the I2‐imidazoline receptor ligand LSL 60101British Journal of Pharmacology, 2000
- 3D-QSAR CoMFA Study on Imidazolinergic I2 Ligands: A Significant Model through a Combined Exploration of Structural Diversity and MethodologyJournal of Medicinal Chemistry, 2000
- Novel Selective Compounds for the Investigation of Imidazoline ReceptorsaAnnals of the New York Academy of Sciences, 1999
- `Seeing through a glass darkly': casting light on imidazoline `I' sitesTrends in Pharmacological Sciences, 1998
- Characterisation and localisation of [
H ]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptorsEuropean Journal of Pharmacology, 1998 - Imidazoline receptor proteins in brains of patients with Alzheimer's diseaseNeuroscience Letters, 1998
- 2-D and 3-D modeling of imidazoline receptor ligands: Insights into pharmacophoreBioorganic & Medicinal Chemistry, 1997
- Immunodetection and Quantitation of Imidazoline Receptor Proteins in Platelets of Patients With Major Depression and in Brains of Suicide VictimsArchives of General Psychiatry, 1996
- Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological functionBritish Journal of Pharmacology, 1992
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973